Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-27 Sale | 2024-02-28 9:56 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 1,000 | $193.35 | $193,350 | 87,367 (Direct) | View |
| 2023-08-29 Sale | 2023-08-30 4:06 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 850 | $171.38 | $145,673 | 83,741 (Direct) | View |
| 2022-09-09 Sale | 2022-09-09 4:14 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 775 | $227.17 | $176,057 | 76,401 (Direct) | View |
| 2022-05-25 Sale | 2022-05-26 5:17 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 14,715 | $150.51 | $2,214,819 | 76,532 (Direct) | View |
| 2021-11-10 Sale | 2021-11-12 5:12 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 4,783 | $263.93 | $1,262,355 | 91,247 (Direct) | View |
| 2021-11-02 Sale | 2021-11-04 5:41 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,400 | $303.94 | $729,467 | 91,247 (Direct) | View |
| 2021-09-14 Sale | 2021-09-15 5:46 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 274 | $294.26 | $80,628 | 93,647 (Direct) | View |
| 2021-09-01 Sale | 2021-09-02 4:29 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 3,459 | $283.91 | $982,058 | 93,921 (Direct) | View |
| 2021-08-17 Sale | 2021-08-19 4:42 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 18,956 | $254.18 | $4,818,219 | 93,921 (Direct) | View |
| 2021-07-20 Sale | 2021-07-22 8:25 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 4,585 | $202.09 | $926,605 | 112,877 (Direct) | View |
| 2021-07-13 Sale(A) | 2021-07-22 6:53 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 1,520 | $202.23 | $307,395 | 117,462 (Direct) | View |
| 2021-07-13 Sale | 2021-07-15 5:17 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 1,520 | $202.23 | $307,390 | 117,462 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 5:01 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 285 | $176.85 | $50,402 | 115,449 (Direct) | View |
| 2021-05-04 Purchase | 2021-05-06 4:29 pm | Vaccitech plc | VACC | DAWES KAREN A Director | 1,700 | $17 | $28,900 | 1,700 (Direct) | View |
| 2020-06-18 Sale | 2020-06-22 4:42 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 18,705 | $115.2 | $2,154,851 | 100,734 (Direct) | View |
| 2020-05-20 Sale | 2020-05-21 9:08 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 517 | $139.44 | $72,093 | 119,439 (Direct) | View |
| 2020-05-18 Sale(A) | 2020-05-21 9:06 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 1,600 | $137.78 | $220,448 | 121,717 (Direct) | View |
| 2020-04-20 Sale(A) | 2020-05-21 9:03 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 12,200 | $104.57 | $1,275,717 | 132,634 (Direct) | View |
| 2020-05-18 Sale | 2020-05-19 8:46 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 1,600 | $137.78 | $220,448 | 121,717 (Direct) | View |
| 2020-05-08 Sale | 2020-05-11 8:23 pm | Assertio Therapeutics Inc | ASRT | DAWES KAREN A Director | 15,834 | $0.7914 | $12,531 | 84,589 (Direct) | View |
| 2020-04-20 Sale | 2020-04-22 6:07 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 12,200 | $104.57 | $1,275,717 | 132,634 (Direct) | View |
| 2020-02-21 Sale | 2020-02-24 5:51 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 4,000 | $98.7 | $394,793 | 113,034 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-14 Exercise | 2024-06-14 5:33 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,953 | $67.71 | 88,170 (Direct) | View |
| 2024-06-14 Exercise | 2024-06-14 5:33 pm | N/A 2029-05-15 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,953 | $0 | 88,170 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-20 6:50 pm | 2025-05-16 2034-05-16 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,379 | $0 | 89,746 (Direct) | View |
| 2024-05-10 Option Award | 2024-05-14 4:23 pm | N/A 2034-05-10 | Barinthus Biotherapeutics plc. | BRNS | DAWES KAREN A Director | 19,516 | $0 | 19,516 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-28 9:56 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 4,626 | $42.07 | 87,367 (Direct) | View |
| 2024-02-27 Exercise | 2024-02-28 9:56 pm | N/A 2028-05-16 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 4,626 | $0 | 87,367 (Direct) | View |
| 2023-08-29 Exercise | 2023-08-30 4:06 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 7,392 | $18.12 | 83,741 (Direct) | View |
| 2023-08-29 Exercise | 2023-08-30 4:06 pm | N/A 2024-05-15 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 7,392 | $0 | 83,741 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-22 9:26 pm | 2024-05-18 2033-05-18 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,528 | $0 | 78,929 (Direct) | View |
| 2023-05-11 Option Award | 2023-05-12 4:05 pm | N/A 2033-05-11 | Vaccitech plc | VACC | DAWES KAREN A Director | 19,197 | $0 | 19,197 (Direct) | View |
| 2022-06-15 Ownership | 2023-02-10 4:34 pm | N/A 2032-06-15 | Vaccitech plc | VACC | DAWES KAREN A Director | 18,604 | $0 | 18,604 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 8:21 pm | 2023-05-26 2032-05-26 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,209 | $0 | 78,741 (Direct) | View |
| 2021-11-10 Exercise | 2021-11-12 5:12 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 4,783 | $26.12 | 91,247 (Direct) | View |
| 2021-11-10 Exercise | 2021-11-12 5:12 pm | N/A 2026-05-11 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 4,783 | $0 | 91,247 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-02 4:29 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 3,459 | $38.76 | 93,921 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-02 4:29 pm | N/A 2027-05-18 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 3,459 | $0 | 93,921 (Direct) | View |
| 2021-07-13 Exercise(A) | 2021-07-22 6:53 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,929 | $41.19 | 117,462 (Direct) | View |
| 2021-07-13 Exercise(A) | 2021-07-22 6:53 pm | N/A 2025-07-21 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,929 | $0 | 117,462 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 5:17 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,929 | $41.19 | 117,462 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 5:17 pm | N/A 2025-07-21 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,929 | $0 | 117,462 (Direct) | View |
| 2021-05-13 Option Award | 2021-05-17 9:50 pm | 2022-05-13 2031-05-13 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,126 | $0 | 117,575 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 5:01 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 15,000 | $3.22 | 115,449 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 5:01 pm | N/A 2021-12-15 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 15,000 | $0 | 115,449 (Direct) | View |
| 2021-04-29 Option Award | 2021-05-04 8:25 pm | N/A 2031-04-29 | Vaccitech plc | VACC | DAWES KAREN A Director | 34,328 | $0 | 34,328 (Direct) | View |
| 2020-05-13 Option Award(A) | 2020-05-21 9:06 pm | 2021-05-13 2030-05-13 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,483 | $0 | 121,717 (Direct) | View |
| 2020-04-20 Exercise(A) | 2020-05-21 9:03 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 20,000 | $3.3 | 132,634 (Direct) | View |
| 2020-04-20 Exercise(A) | 2020-05-21 9:03 pm | N/A 2020-09-16 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 20,000 | $0 | 132,634 (Direct) | View |
| 2020-05-13 Option Award | 2020-05-19 8:46 pm | 2021-05-13 2030-05-13 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,483 | $0 | 121,717 (Direct) | View |
| 2020-04-20 Exercise | 2020-04-22 6:07 pm | N/A N/A | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 20,000 | $3.3 | 132,634 (Direct) | View |
| 2020-04-20 Exercise | 2020-04-22 6:07 pm | N/A 2020-09-16 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 20,000 | $0 | 132,634 (Direct) | View |